Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prime Regenerative is a healthcare company and wholesale supplier specializing in regenerative medicine solutions for medical practices across the United States. Founded in 2016, the company provides a comprehensive suite of premium-grade biologics, including Wharton's Jelly, mesenchymal stem cells (MSCs), exosomes, and Platelet-Rich Plasma (PRP) kits. In addition to biological products, Prime Regenerative offers advanced medical equipment such as the RegenWave shockwave therapy device. The company also provides "done-for-you" marketing and training support through its Patient Rocket Program to help clinics integrate and scale regenerative treatments effectively.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prime Regenerative.